Hassallidins, antifungal glycolipopeptides, are widespread among cyanobacteria and are the end-product of a nonribosomal pathway

Proceedings of the National Academy of Sciences of the United States of America

Volumn 111, Issue 18, 2014, Pages

  Vestola, Johanna ^a   Shishido, Tania K ^a   Jokela, Jouni ^a   Fewer, David P ^a   Aitio, Olli ^b   Permi, Perttu ^b   Wahlsten, Matti ^a   Wang, Hao ^a   Rouhiainen, Leo ^a   Sivonen, Kaarina ^a  

^a UNIVERSITY OF HELSINKI   (Finland)

^b UNIVERSITY OF HELSINKI   (Finland)

Author keywords

Bioactive peptide; Genome mining; Natural product discovery; Nonribosomal peptide synthesis; Secondary metabolites

Indexed keywords

AMINO ACID; ANTIFUNGAL AGENT; CARBOHYDRATE; CONTIG; FATTY ACID; HASSALLIDIN A; HASSALLIDIN B; LIPOPEPTIDE; NONRIBOSOMAL PEPTIDE SYNTHETASE; UNCLASSIFIED DRUG;

ACETYLATION; ANABAENA; ANTIFUNGAL ACTIVITY; APHANIZOMENON; ARTICLE; BACTERIAL GENE; BACTERIAL GENOME; BACTERIAL STRAIN; BIOINFORMATICS; BIOSYNTHESIS; CANDIDA ALBICANS; CONTROLLED STUDY; CYLINDROSPERMOPSIS; GENE CLUSTER; GENE SEQUENCE; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; NOSTOC; PRIORITY JOURNAL; TOLYPOTHRIX;

BIOACTIVE PEPTIDE; GENOME MINING; NATURAL PRODUCT DISCOVERY; NONRIBOSOMAL PEPTIDE SYNTHESIS; SECONDARY METABOLITES;

ANABAENA; ANTIFUNGAL AGENTS; CANDIDA ALBICANS; CYANOBACTERIA; GENES, BACTERIAL; GLYCOLIPIDS; GLYCOPEPTIDES; HUMANS; LIPOPEPTIDES; METABOLIC NETWORKS AND PATHWAYS; MOLECULAR SEQUENCE DATA; MOLECULAR STRUCTURE; MULTIGENE FAMILY; NUCLEAR MAGNETIC RESONANCE, BIOMOLECULAR; PEPTIDES, CYCLIC; PHYLOGENY;

EID: 84899860203     PISSN: 00278424     EISSN: 10916490     Source Type: Journal    
DOI: 10.1073/pnas.1320913111     Document Type: Article

References (57)

1. Sivonen K (2009) The Encyclopedia of Microbiology, ed Schaechter M (Academic, Oxford), 3rd Ed, pp 290-307.
2. Burja AM, Banaigs B, Abou-Mansour E, Burgess JG, Wright PC (2001) Marine cyanobacteria-Profilic source of natural products. Tetrahedron 57(46):9347-9377.
3. Sivonen K, Börner T (2008) The Cyanobacteria: Molecular Biology, Genetics and Evolution, eds Herrero A, Flores E (Academic, Norfolk, UK), pp 159-198.
4. Welker M, von Döhren H (2006) Cyanobacterial peptides-Nature's own combinatorial biosynthesis. FEMS Microbiol Rev 30(4):530-563.
5. Finking R, Marahiel MA (2004) Biosynthesis of nonribosomal peptides1. Annu Rev Microbiol 58:453-488.
6. Sieber SA, Marahiel MA (2005) Molecular mechanisms underlying nonribosomal peptide synthesis: Approaches to new antibiotics. Chem Rev 105(2): 715-738.
7. Marahiel MA, Stachelhaus T, Mootz HD (1997) Modular peptide synthetases involved in nonribosomal peptide synthesis. Chem Rev 97(7):2651-2674.
8. Schwarzer D, Finking R, Marahiel MA (2003) Nonribosomal peptides: From genes to products. Nat Prod Rep 20(3):275-287.
9. Fischbach MA, Walsh CT (2006) Assembly-line enzymology for polyketide and nonribosomal peptide antibiotics: Logic, machinery, and mechanisms. Chem Rev 106(8):3468-3496.
10. Challis GL, Ravel J , Townsend CA (2000) Predictive, structure-based model of amino acid recognition by nonribosomal peptide synthetase adenylation domains. Chem Biol 7(3):211-224.
11. Walsh CT, Fischbach MA (2010) Natural products version 2.0: Connecting genes to molecules. J Am Chem Soc 132(8):2469-2493.
12. Shih PM, et al. (2013) Improving the coverage of the cyanobacterial phylum using diversity-driven genome sequencing. Proc Natl Acad Sci USA 110(3):1053-1058.
13. Rouhiainen L, et al. (2000) Genes encoding synthetases of cyclic depsipeptides, anabaenopeptilides, in Anabaena strain Mol Microbiol 37(1):156-167.
14. Rouhiainen L, et al. (2004) Genes coding for hepatotoxic heptapeptides (microcystins) in the cyanobacterium Anabaena strain 90. Appl Environ Microbiol 70(2):686-92.
15. Rouhiainen L, Jokela J, Fewer DP, Urmann M, Sivonen K (2010) Two alternative starter modules for the non-ribosomal biosynthesis of specific anabaenopeptin variants in Anabaena (Cyanobacteria). Chem Biol 17(3):265-273.
16. Wang H, et al. (2012) Genome-derived insights into the biology of the hepatotoxic bloom-forming cyanobacterium Anabaena sp. Strain 90. BMC Genomics 13:613.
17. Neuhof T, et al. (2005) Hassallidin A, a glycosylated lipopeptide with antifungal activity from the cyanobacterium Hassallia sp. J Nat Prod 68(5):695-700.
18. Neuhof T, Schmieder P, Seibold M, Preussel K, von Döhren H (2006) Hassallidin B-Second antifungal member of the Hassallidin family. Bioorg Med Chem Lett 16(16): 4220-4222.
19. Scaloni A, et al. (2004) Structure, conformation and biological activity of a novel lipodepsipeptide from Pseudomonas corrugata: Cormycin A. Biochem J 384(Pt 1): 25-36.
20. Salas JA, Méndez C (2007) Engineering the glycosylation of natural products in actinomycetes. Trends Microbiol 15(5):219-232.
21. Menéndez N, et al. (2004) Biosynthesis of the antitumor chromomycin A3 in Streptomyces griseus: Analysis of the gene cluster and rational design of novel chromomycin analogs. Chem Biol 11(1):21-32.
22. Teichmann B, Linne U, Hewald S, Marahiel MA, Bölker M (2007) A biosynthetic gene cluster for a secreted cellobiose lipid with antifungal activity from Ustilago maydis. Mol Microbiol 66(2):525-533.
23. Teichmann B, et al. (2011) Identification of a biosynthesis gene cluster for flocculosin a cellobiose lipid produced by the biocontrol agent Pseudozyma flocculosa. Mol Microbiol 79(6):1483-1495 .
24. Schwartz RE et al. 1990 Pharmaceuticals from cultured algae J Ind Microbiol 5 2-3 113-124
25. Edelman MJ, et al. (2003) Phase 2 study of cryptophycin 52 (LY355703) in patients previously treated with platinum based chemotherapy for advanced non-small cell lung cancer. Lung Cancer 39(2):197-199.
26. Singh IP, Milligan KE, Gerwick WH (1999) Tanikolide, a toxic and antifungal lactone from the marine cyanobacterium Lyngbya majuscula. J Nat Prod 62(9):1333-1335.
27. Kobayashi A, Kajiyama S-I (1998) Secondary metabolites of cyanobacteria Nostoc sp. Chin J Oceanology Limnol 16(Suppl 1):109-117.
28. Neuhof T, et al. (2006) Lipopeptides having pharmaceutical activity. Patent analysis, 1698638 EP.
29. Choi BW, et al. (1993) Isolation of linear peptides related to the hepatotoxins nodularin and microcystins. Tetrahedron Lett 34(49):7881-7884.
30. Herfindal L, et al. (2011) Nostocyclopeptide-M1: A potent, nontoxic inhibitor of the hepatocyte drug transporters OATP1B3 and OATP1B1. Mol Pharm 8(2):360-367.
31. Menéndez N, e t al. (2004) Tailoring modification of deoxysugars during biosynthesis of the antitumour drug chromomycin A by Streptomyces griseus ssp. griseus. Mol Microbiol 53(3):903-915.
32. Ostash B, et al. (2004) Generation of new landomycins by combinatorial biosynthetic manipulation of the LndGT4 gene of the landomycin E cluster in S. globisporus. Chem Biol 11(4):547-555.
33. Neuhof T, et al. (2006) Comparison of susceptibility and transcription profile of the new antifungal hassallidin A with caspofungin. Biochem Biophys Res Commun 349(2): 740-749.
34. Vicente MF, Basilio A, Cabello A, Peláez F (2003) Microbial natural products as a source of antifungals. Clin Microbiol Infect 9(1):15-32.
35. Luzhetskyy A, Bechthold A (2008) Features and applications of bacterial glycosyltransferases: Current state and prospects. Appl Microbiol Biotechnol 80(6):945-952.
36. Luzhetskyy A, et al. (2005) Iteratively acting glycosyltransferases involved in the hexasaccharide biosynthesis of landomycin A. Chem Biol 12(7):725-729.
37. Rausch C, Hoof I, Weber T, Wohlleben W, Huson DH (2007) Phylogenetic analysis of condensation domains in NRPS sheds light on their functio nal evolution. BMC Evol Biol 7:78.
38. Moffitt MC, Neilan BA (2004) Characterization of the nodularin synthetase gene cluster and proposed theory of the evolution of cyanobacterial hepatotoxins. Appl Environ Microbiol 70(11):6353-6362.
39. Sano T, Beattie KA, Codd GA, Kaya K (1998) Two (Z)-dehydrobutyrine- containing microcystins from a hepatotoxic bloom of Oscillatoria agardhii from Soulseat Loch, Scotland. J Nat Prod 61(6):85 1-853.
40. Lagos N, et al. (1999) The first evidence of paralytic shellfish toxins in the fresh water cyanobacterium Cylindrospermopsis raciborskii, isolated from Brazil. Toxicon 37(10): 1359-1373.
41. Stucken K, et al. (2010) The smallest known genomes of multicellular and toxic cyanobacteria: Comparison, minimal gene sets for linked traits and the evolutionary implications. PLoS ONE 5(2):e9235.
42. Mihali TK, Kellmann R, Muenchhoff J, Barrow KD, Neilan BA (2008) Characterization of the gene cluster responsible for cylindrospermopsin biosynthesis. Appl Environ Microbiol 74(3):71 6-722.
43. Hawkins PR, Runnegar MT, Jackson AR, Falconer IR (1985) Severe hepatotoxicity caused by the tropical cyanobacterium (blue-green alga) Cylindrospermopsis raciborskii (Woloszynska) Seenaya and Subba Raju isolated from a domestic water supply reservoir. Appl Environ Microbiol 50(5):1292-1295.
44. Ohtani I, Moore RE, Runnegar MTC (1992) Cylindrospermopsin: A potent hepatotoxin from the blue-green alga Cylindrospermopsis raciborskii. J Am Chem Soc 114(20): 7941-7942.
45. Griffiths DJ Saker ML 2003 The Palm Island mystery disease 20 years on: A review of research on the cyanotoxin cylindrospermopsin Environ Toxicol 18 2 78-93
46. SønstebøJH, Rohrlack T (2011) Possible implications of chytrid parasitism for population subdivision in freshwater cyanobacteria of the genus Planktothrix. Appl Environ Microbiol 77(4):1344-1351.
47. Rohrlack T, Christiansen G, Kurmayer R (2013) Putative antiparasite defensive system involving ribosomal and nonribosomal oligopeptides in cyanobacteria o f the genus Planktothrix. Appl Environ Microbiol 79(8):2642-2647.
48. Czeczuga B, Orlowska M (2000) Investigations on the joint occurrence of Anabaena spiroides Klebahn and hyphomycetes in various t ypes of water bodies. Acta Hydrochim Hydrobiol 28(3):162-165.
49. Kótai J (1972) Instructions for Preparation of Modified Nutrient Solution Z8 for Algae, Blindern B-11/69 (Norwegian Institute for Water Research, Oslo).
50. Zdobnov EM, Apweiler R (2001) InterProScan-An integration platform for the signature-recognition methods in InterPro. Bioinformatics 17(9):847-848.
51. Bachmann BO, Ravel J (2009) Chapter 8. Methods for in silico prediction of microbial polyketide and nonribosomal peptide biosynthetic pathways from DNA sequence data. Methods Enzymol 458:181-217.
52. Stachelhaus T, Mootz HD, Marahiel MA (1999) The specificity-conferring code of adenylation domains in nonribosomal peptide synthetases. Chem Biol 6(8):493-505.
53. Rausch C, Weber T, Kohlbacher O, Wohlleben W, Huson DH (2005) Specificity prediction of adenylation domains in nonribosomal peptide synthetases (NRPS) using transductive support vector machines (TSVMs). Nucleic Acids Res 33(1 8):5799-5808.
54. Tamura K, et al. (2011) MEGA5: Molecular evolutionary genetics analysis using maximum likelihood, evolutionary distance, and maximum parsimony methods. Mol Biol Evol 28(10):2731-2739.
55. Leikoski N, et al. (2012) Analysis of an inactive cyanobactin biosynthetic gene cluster leads to discovery of new natural products from strains of the genus Microcystis. PLoS ONE 7(8):e43002.
56. Leikoski N, et al. (2013) Genome mining expands the chemical diversity of the cyanobactin family to include highly modified linear peptides. Chem Biol 20(8):1033-1043.
57. Clinical and Laboratory Standards Institute (2008) Method for Broth Dilution Antifungal Susceptibility Testing of Yeasts; Approved Standard (Clinical and Laboratory Standards Institute, Wayne, PA), 3rd Ed, pp. 1-20.